Table 1.
Patients’ laboratory results
| Parameter | Mean ± SD | (Min,Max) | Median (IQR) |
|---|---|---|---|
| Age (years) | 46.2 ± 11.5 | (20, 85) | 46 (38–53) |
| HIV Duration (months) | 110.7 ± 92.8 | (1, 381) | 84 (37–168) |
| Duration of treatment (months) | 88.0 ± 84.9 | (0, 348) | 59.5 (16–134) |
| BMI | 24.6 ± 3.5 | (18.3, 38.0) | 24.2 (22.3–26.4) |
| ALP (IU/ml) | 73.6 ± 25.6 | (9, 180) | 70.0 (56.0–85.0) |
| ALT (IU/ml) | 32.7 ± 29.8 | (8, 286) | 24.0 (20–32.5) |
| AST (Iu/ml) | 28.56 ± 22.32 | (9, 230) | 24.0 (20.0–28.0) |
| Bil (mg/dl) | 0.62 ± 0.59 | (0.16, 6.38) | 0.49 (0.36–0.67) |
| gGT (IU/ml) | 42.2 ± 46.7 | (8, 343) | 28.0 (18.0–44.0) |
| PLTs (k/μl) | 213,963 ± 62,336 | (65,000, 608,000) | 205,000 (176,000-242,000) |
| TRG (mg/dl) | 155.9 ± 114.2 | (41, 761) | 124.0 (97.0–167.0) |
| CHOL (mg/dl) | 190.1 ± 46.7 | (77, 313) | 189.0 (154.0–218.0) |
| CD4 (cells/μL) | 697.6 ± 380.7 | (10, 1881) | 660.0 (412.0–909.0) |
| CD4 / CD8 | 0.70 ± 0.42 | (0.03, 2.22) | 0.65 (0.38–0.95) |
| Months of CD4 less than 50 cells/μL | 1.48 ± 9.2 | (0, 120) | 0 (0–0) |
| Months of CD4 less than 200 cells/μL | 6.71 ± 20.43 | (0, 240) | 0 (0–6) |
| Months of CD4 less than 350 cells/μL | 19.22 ± 35.76 | (0, 289) | 5 (0–20) |
| Months of VL higher than 50 cop/ml | 31.48 ± 43.85 | (0, 225) | 12 (5–39) |
| Number of LREs | 0.42 ± 0.78 | (0, 5) | 0 (0–1) |
| Events of transaminasemia | 0.59 ± 1.13 | (0, 5) | 0 (0–1) |
BMI Body-mass index, ALP Alkaline phosphatase, ALT Alanine aminotransferase, AST Aspartate aminotransferase, Bil Total Bilirubin, gGT gamma glutamyl-transferase, PLTs platelets, TRG triglycerides, CHOL cholesterol, VL Viral load, LREs Liver related events.